GlassScriptPhysician profile
Kenneth M Leclerc
NPI 1760483754
$2,831.56
in general payments reported to CMS, 2019-2025
16 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $48.48 · 2021: $62.77 · 2022: $1,735 · 2023: $417 · 2024: $252 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,678.61 | 2022-2024 | Aveir |
| Boston Scientific Corporation | $397.24 | 2019-2024 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $134.16 | 2022-2023 | Micra |
| Impulse Dynamics (USA) INC. | $100.77 | 2023 | Optimizer |
| Abiomed | $90.00 | 2024 | Impella |
| Pfizer INC. | $87.56 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $72.76 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.86 | 2019-2024 | Lifevest |
| Amgen INC. | $57.73 | 2020-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $32.96 | 2025 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $26.65 | 2024 | Arcalyst |
| Heartflow, INC. | $23.33 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.28 | 2021 | |
| Amarin Pharma, INC. | $19.26 | 2020 | |
| Medtronic Vascular, INC. | $18.50 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Leclerc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.